Jan 8 (Reuters) - Coya Therapeutics Inc COYA.O:
COYA THERAPEUTICS ANNOUNCES RESULTS OF INVESTIGATOR-INITIATED STUDY OF LD IL-2 AND CTLA4-IG DEMONSTRATING TREG ENHANCEMENT AND COGNITIVE STABILITY IN FRONTOTEMPORAL DEMENTIA PATIENTS
Source text: ID:nBwFB3b6a
Further company coverage: COYA.O
((Reuters.Briefs@thomsonreuters.com;))